Since the NK cell-mediated cytotoxicity is regulated by the balance between activating and inhibiting signals,[28] it is of particular interest to understand if cytotoxic anticancer drugs and EGFR-TKI affect the expression of activating NK cell receptors in NSCLC cells. This evidence concerns the gene EGFR and non-small cell lung carcinoma.